View Post

Pancreatic cancer trial: Early surgery boosts success rates

In In The News by Barbara Jacoby0 Comments

From: bbc.com Speeding up access to surgery for pancreatic cancer patients diagnosed early enough increased success rates by a third, a pilot scheme has shown. The Birmingham team said it had saved the NHS £3,200 per patient and could help hundreds of patients UK-wide. The trial involved cutting average time to surgery for 32 patients from two months to just …

View Post

Blood test launched that monitors the cancer’s ‘DNA’

In In The News by Barbara Jacoby0 Comments

By: Stephen Matthews From: dailymail.co.uk A new ‘smart blood test’ could revolutionise cancer treatment by matching patients to the most effective care earlier. Liquid biopsies, which would cost between £200 and £300, could become a standard part of patient care within just two years, experts believe. A groundbreaking clinical trial involving 1,000 breast cancer patients will be launched in the …

View Post

Breast cancer drug rejected despite doubling in tumour destruction

In In The News by Barbara Jacoby0 Comments

By: Laura Donnelly From: telegraph.co.uk A breast cancer drug that has been shown to almost double the eradication of tumours has been rejected for use on the NHS. In draft guidance, the National Institute for Health and Care Excellence (Nice) said it was uncertain how the effects of Perjeta (also called pertuzumab) seen in clinical trials would translate into long-term …

View Post

Head and neck cancer drug ‘game changer’

In In The News by Barbara Jacoby0 Comments

By: Michelle Roberts From: bbc.com A new type of cancer drug that wakes up the patient’s own immune system to fight tumours could be a game changer for tackling aggressive head and neck cancers, say experts. Trial results coming out of a US cancer conference suggest the treatment works better than standard chemotherapy. Nivolumab significantly improved the survival odds of …

View Post

Why ARE health chiefs denying lung cancer patients the wonder drug that brought this woman back from the brink?

In In The News by Barbara Jacoby0 Comments

By: Antonia Hoyle From: dailymail.co.uk Cancer Drugs Fund was set up to allow patients to buy pricey medicines CDF could’ve been a last-chance saloon for patients desperate for Zykadia  The drug works by blocking a cancer-causing protein in rare lung cancers  But NICE said the drug wasn’t a ‘cost-efficient’ use of NHS resources I don’t know Demi Pestell, but after …

View Post

HUNDREDS of cancer victims given hope as drug ‘cure’ is fast-tracked

In In The News by Barbara Jacoby0 Comments

By: Lucy Johnston From: express.co.uk A REVOLUTIONARY cancer drug expected to save hundreds of lives a year has been deemed so effective that the Government has bypassed red tape to make it available on the NHS immediately. From tomorrow patients with advanced kidney cancer will be able to access the landmark drug nivolumab.The treatment has not yet been given a …

View Post

Proton beam cancer therapy has ‘fewer side effects’

In In The News by Barbara Jacoby0 Comments

By: Dominic Howell From: bbc.com A cancer treatment at the centre of an NHS controversy in 2014 causes fewer side effects in children than conventional radiotherapy, according to new research. The study, published in The Lancet Oncology, suggests proton beam therapy is as effective as other treatments. Researchers looked at 59 patients aged between three and 21 from 2003 to …

View Post

UK Green-Lights New Drug For Advanced Skin Cancer

In In The News by Barbara Jacoby0 Comments

By: Katrina Pascual From: techtimes.com Pharmaceutical company Bristol-Myers Squibb has received a nod from United Kingdom’s health cost regulators for the use of its drug Opdivo (nivolumab) in skin cancer cases. The company previously failed to obtain the same recommendation from the National Institute for Health and Care Excellence (NICE) for Opdivo as lung tumor treatment. Following the approval, the …

View Post

Breast cancer drug Kadcyla to remain on NHS after manufacturer lowers price

In In The News by Barbara Jacoby0 Comments

By: Sarah Boseley From: theguardian.com Drug was set to be dumped from UK’s list of approved medicines before deal was reached with pharmaceutical firm Roche An expensive drug that could prolong the lives of women with advanced breast cancer by at least six months will remain on the list of medicines available on the NHS after the manufacturer agreed to …

View Post

Thousands of cancer patients to be denied treatment

In In The News by Barbara Jacoby0 Comments

By:Laura Donnelly From: telegraph.co.uk More than 5,000 cancer patients will be denied life-extending drugs under plans which charities say are a “dreadful” step backwards for the NHS. Health officials have just announced sweeping restrictions on treatment, which will mean patients with breast, bowel, skin and pancreatic cancer will no longer be able to receive drugs funded by the NHS. In …